Mono Pharmacare Limited (NSE:MONOPHARMA)

Market Cap	301.25M
Revenue (ttm)	1.48B
Net Income (ttm)	8.33M
Shares Out	17.67M
EPS (ttm)	0.43
PE Ratio	39.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Average Volume	11,100
Open	17.90
Previous Close	17.05
Day's Range	17.90 - 17.90
52-Week Range	16.95 - 36.20
Beta	-1.91
RSI	32.67
Earnings Date	Nov 14, 2025

About Mono Pharmacare

Mono Pharmacare Limited engages in the distribution of pharmaceutical items in India. The company markets healthcare products, such as antibiotics, cough cold anti allergics, antifungal, nutraceutical, analgesic and antipyretic, antacid and antiemetic, cardiac diabetic, skincare, antiseptic, bronchodilators, probiotics, and antihistamines. It also offers products under the Cosmo Care brand; eye and ear drops, nasal spray, gynec, herbal, and skincare products. The company was founded in 1964 and is based in Ahmedabad, India.

• Industry: Medical Distribution
• Sector: Industrials
• Founded: 1964
• Employees: 115
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MONOPHARMA

Financial Performance

In 2024, Mono Pharmacare's revenue was 1.68 billion, an increase of 37.65% compared to the previous year's 1.22 billion. Earnings were 30.90 million, an increase of 26.52%.